Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 15/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

18%

4 trials in Phase 3/4

Results Transparency

71%

5 of 7 completed with results

Key Signals

5 with results88% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (5)
P 1 (2)
P 2 (5)
P 3 (1)
P 4 (3)

Trial Status

Completed7
Recruiting5
Unknown5
Active Not Recruiting2
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT02081326Phase 2Active Not Recruiting

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

NCT06670625Not ApplicableRecruiting

Intensive Dietary and Activity Counselling (IDAC)

NCT07522502Completed

Metabolic and Immunoinflammatory Profiles in Adults With Newly Diagnosed Diabetes

NCT05866536Phase 2Recruiting

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

NCT05180591Phase 2Recruiting

Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes

NCT04902807Recruiting

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

NCT03945747Active Not Recruiting

MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus

NCT05168657Not ApplicableCompleted

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

NCT05319990Recruiting

Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)

NCT03011021Phase 1Unknown

Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes

NCT04074668Completed

Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance

NCT03345004Phase 2Completed

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes

NCT04335513Not ApplicableUnknown

Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D

NCT03618420Phase 1Completed

Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function

NCT04698330Phase 4Not Yet Recruiting

Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

NCT04793165Not ApplicableCompleted

Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient Setting

NCT03011008Phase 4Unknown

Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

NCT03513874Phase 4Unknown

Metformin Plus Insulin on Non-obese Autoimmune Diabetes

NCT01881009Not ApplicableCompleted

Medtronic Minimed Overnight Closed-Loop System

NCT01559025Phase 3Unknown

Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus

Scroll to load more

Research Network

Activity Timeline